Silencing Histone Deacetylase 7 Alleviates Transforming Growth Factor-β1-Induced Profibrotic Responses in Fibroblasts Derived from Peyronie's Plaque
Open Access
- 1 January 2018
- journal article
- research article
- Published by XMLink in The World Journal of Men's Health
- Vol. 36 (2) , 139-146
Abstract
Kang DH, et al. World J Mens Health. 2018 Jan;36:e11. https://doi.org/10.5534/wjmh.170005Keywords
Funding Information
- National Research Foundation of Korea (2016R1A2B4013130)
This publication has 25 references indexed in Scilit:
- Histone Deacetylase: A Potential Therapeutic Target for Fibrotic DisordersThe Journal of Pharmacology and Experimental Therapeutics, 2010
- Transforming Growth Factor (TGF)-β Type I Receptor Kinase (ALK5) Inhibitor Alleviates Profibrotic TGF-β1 Responses in Fibroblasts Derived from Peyronie’s PlaqueThe Journal of Sexual Medicine, 2010
- Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosisNature Chemical Biology, 2009
- Abrogation of TGF-β1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibitionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathyAmerican Journal of Physiology-Renal Physiology, 2009
- Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-β1-induced renal injuryAmerican Journal of Physiology-Renal Physiology, 2009
- Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosisArthritis & Rheumatism, 2009
- Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin‐induced skin fibrosisArthritis & Rheumatism, 2007
- Peyronie’s Disease: A ReviewJournal of Urology, 2003
- Proposal: Trauma as the Cause of the Peyronie's LesionJournal of Urology, 1997